White House economists estimate Trump drug deals save economy $529bn over 10 years
Updated
Updated · The Associated Press · May 5
White House economists estimate Trump drug deals save economy $529bn over 10 years
9 articles · Updated · The Associated Press · May 5
The analysis also projected $64.3 billion in Medicaid savings and was prepared for the White House Council of Economic Advisers in Washington.
The administration says agreements with 17 major drugmakers would align some US prices with those abroad, while another model put potential decade-long savings at $733 billion.
Democrats have questioned the unpublished deal terms and assumptions, as Trump pushes Congress to codify the policy before November midterm elections amid wider cost-of-living concerns.
How can the U.S. save $529 billion while drug companies in the deal still project rising profits?
Since TrumpRx discounts are for cash-payers, how does this policy actually lower costs for insured Americans?
Will lower U.S. drug prices lead to fewer life-saving medical innovations for future patients?